Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Clinicopathological features and diagnostic methods of ALK fusion-positive non-small cell lung cancer in Korea

Authors
Chang, Won ChulKim, Han KyeomShin, Bong Kyung
Issue Date
1월-2020
Publisher
SPANDIDOS PUBL LTD
Keywords
non-small cell lung cancer; ALK fusion; ALK FISH; ALK IHC; next-generation sequencing
Citation
ONCOLOGY REPORTS, v.43, no.1, pp.218 - 228
Indexed
SCIE
SCOPUS
Journal Title
ONCOLOGY REPORTS
Volume
43
Number
1
Start Page
218
End Page
228
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/58394
DOI
10.3892/or.2019.7399
ISSN
1021-335X
Abstract
Lung cancer is one of the most common malignancies and the leading cause of cancer-associated mortality in Korea. A significant amount of effort has been put into the development of new and more effective treatments and biological markers for the prediction of therapeutic responses, which has led to the identification of various genetic changes in cancer, that are the so-called 'growth drivers' of carcinogenesis. Certain genetic alterations have become new treatment targets, and it has been suggested that different mutations are associated with different clinicopathological characteristics and prognosis. The present study aimed to evaluate the status of the key 'driver' mutation anaplastic lymphoma kinase (ALK) fusion in Korean patients with non-small cell lung cancer (NSCLC) and its association with clinicopathological characteristics, including the presence of other genetic mutations. The present study also compared different methods for ALK fusion detection, including fluorescence in situ hybridization (FISH), immunohistochemistry (IHC) and next-generation sequencing (NGS) to evaluate which method is the most effective. A total of 482 patients with NSCLC who underwent ALK FISH analysis were evaluated for clinicopathological features, such as age, sex, smoking history, tumor stage, histological subtype, immunohistochemical profile, including ALK and EGFR mutation statuses, and survival. Some ALK FISH-positive and -negative cancers were newly submitted to NGS analysis for DNA and RNA alterations. The ALK fusion-positive tumors were associated with a younger age, female patients, frequent nodal metastases, advanced stage and shorter survival. Comparing the results of ALK FISH, IHC and NGS analyses, it was concluded that in practice, ALK testing should better be diversified concerning FISH and IHC, and NGS analysis would be a good alternative to FISH, with an additional advantage of being able to concurrently detect different mutations.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE